HCC: The role of immunotherapy beyond advanced HCC

December 06, 2023 00:29:42
HCC: The role of immunotherapy beyond advanced HCC
COR2ED - Oncology Medical Conversation
HCC: The role of immunotherapy beyond advanced HCC

Dec 06 2023 | 00:29:42

/

Show Notes

In this podcast, liver cancer experts Prof. Amit Singal and Assoc. Prof Neil Mehta discuss recent advances in systemic and locoregional therapy for advanced and early stage hepatocellular carcinoma (HCC).  They focus on the role of immunotherapy and review data from three major congresses in 2022 (ASCO, WCGIC and ILC) together with recent publications. 

Prof. Amit Singal is Director of Liver Cancer Program at UT Southwestern Medical Center, Dallas, TX, USA and Assoc. Prof. Neil Mehta is Director of Liver Cancer Program at University of California San Francisco, USA.

Other Episodes

Episode

December 06, 2023 00:26:17
Episode Cover

Breast cancer: Oral SERDs in ER+ BC. Part 3 - Rare cases & treatment challenges

In this final episode, the experts discuss two patient case studies with oral SERDs (oral selective estrogen receptor degraders) and a novel therapy for...

Listen

Episode

December 06, 2023 00:22:48
Episode Cover

Prostate cancer: Which mCSPC patients benefit from early treatment intensification? Case-based discussion

Assoc. Prof. Shilpa Gupta and Dr Fabio Schutz, discuss early treatment intensification with triplet therapy for metastatic castration-sensitive prostate cancer (mCSPC) in this GU...

Listen

Episode

December 06, 2023 00:21:09
Episode Cover

Colorectal cancer: Treatment sequencing in advanced mCRC

This podcast episode discusses treatment sequencing in advanced metastatic colorectal cancer (mCRC) patients, third line and beyond.  Dr Shubham Pant from MD Anderson Cancer...

Listen